Dan Ferry
Host, LifeSci Advisors
Replay available
Mineralys Therapeutics, Inc. (MLYS) Q2 2026 Earnings Call
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jon Congleton
Chief Executive Officer, Mineralis Therapeutics
Eric Warren
Chief Commercial Officer, Mineralis Therapeutics
Adam Levy
Chief Financial Officer, Mineralis Therapeutics
Richard Law
Analyst, Goldman Sachs
Michael DeFiore
Analyst, Evercore ISI
Jason Gerberry
Analyst, Bank of America
Evan Lang
Analyst, Guggenheim Securities (for Seamus Fernandez)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Mineralys Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.234 Welcome to the Mineralis Therapeutics second quarter 2026 conference call. 00:00:05.234 -- 00:00:08.176 At this time, all participants are in a listen-only mode. 00:00:08.176 -- 00:00:11.999 A brief question and answer session will follow the formal presentation. 00:00:11.999 -- 00:00:16.121 Should anyone require operator assistance during the conference, please press star zero 00:00:16.121 -- 00:00:20.624 on your telephone keypad. As a reminder, this conference is being recorded. 00:00:20.624 -- 00:00:24.907 It is now my pleasure to introduce your host, Dan Ferry of LifeSci Advisors. 00:00:24.907 -- 00:00:27.427 Please go ahead, sir. 00:00:27.849 -- 00:00:29.984 Thank you. 00:00:29.984 -- 00:00:34.148 I would like to welcome everyone joining us today for our second quarter 2026 conference 00:00:34.148 -- 00:00:39.192 call. This afternoon, after the close of market trading, we issued a press 00:00:39.192 -- 00:00:44.236 release providing our second quarter 2026 financial results and business updates. 00:00:44.236 -- 00:00:48.280 A replay of today's call will be available on the investor section of our website approximately 00:00:48.280 -- 00:00:51.223 one hour after its completion. 00:00:51.223 -- 00:00:55.519 After our prepared remarks, we will open the call for Q&A. 00:00:55.519 -- 00:00:58.940 Before we begin, I would like to remind everyone that this conference call and webcast 00:00:58.940 -- 00:01:02.701 will contain forward-looking statements about the company. 00:01:02.701 -- 00:01:07.522 Actual results could differ materially from those stated or implied by these forward-looking 00:01:07.522 -- 00:01:11.604 statements due to risks and uncertainties associated with the company's business. 00:01:11.604 -- 00:01:15.325 These ...